Cargando…

Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature

PURPOSE: Papillary thyroid carcinoma (PTC), the most frequent type of malignant thyroid tumor, lacks novel and reliable biomarkers of patients’ prognosis. In the current study, we mined The Cancer Genome Atlas (TCGA) to develop lncRNA signature of PTC. PATIENTS AND METHODS: The intersection of PTC l...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Xin, Yang, Sheng, Sui, Jing, Wu, Wenjuan, Liu, Tong, Xu, Siyi, Cheng, Yanping, Kong, Xiaoling, Liang, Geyu, Yao, Yongzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183593/ https://www.ncbi.nlm.nih.gov/pubmed/30349364 http://dx.doi.org/10.2147/CMAR.S174874

Ejemplares similares

Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database
por: Wu, Wenjuan, et al.
Publicado: (2019)

Systematic analyses of a novel lncRNA‐associated signature as the prognostic biomarker for Hepatocellular Carcinoma
por: Sui, Jing, et al.
Publicado: (2018)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

LncRNA‐LOC101928316 contributes to gastric cancer progression through regulating PI3K‐Akt‐mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2019)

Integrated analysis of long noncoding RNA interactions reveals the potential role in progression of human papillary thyroid cancer
por: You, Xin, et al.
Publicado: (2018)

A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2021)

LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer
por: Luzón-Toro, B., et al.
Publicado: (2019)

A cell cycle–related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma
por: Li, Shuang, et al.
Publicado: (2023)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)

Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer
por: Lin, Zhiheng, et al.
Publicado: (2022)

Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2017)

Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma
por: Zhu, Hui, et al.
Publicado: (2016)

BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer
por: Liao, Tian, et al.
Publicado: (2016)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma
por: Fu, Yi, et al.
Publicado: (2021)

Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer
por: Zhao, Yangjing, et al.
Publicado: (2018)

LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma
por: Shen, Yanyan, et al.
Publicado: (2018)

Curcumin Inhibits Papillary Thyroid Cancer Cell Proliferation by Regulating lncRNA LINC00691
por: Li, Zhihua, et al.
Publicado: (2022)

Development of prognostic signatures for intermediate-risk papillary thyroid cancer
por: Brennan, Kevin, et al.
Publicado: (2016)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Integrative Analysis Reveals a Nine TP53 Pathway-Related lncRNA Prognostic Signature in Endometrial Cancer
por: Wang, Ying, et al.
Publicado: (2022)

LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer
por: Song, Bin, et al.
Publicado: (2019)

LncRNA WT1-AS Downregulates Survivin by Upregulating miR-203 in Papillary Thyroid Carcinoma
por: Le, Fei, et al.
Publicado: (2020)

Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma
por: Li, Li, et al.
Publicado: (2021)

Characterization of lncRNA-Based ceRNA Network and Potential Prognostic Hub Genes for Sepsis
por: Tong, Yiqing, et al.
Publicado: (2022)

Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer
por: Miao, Yan, et al.
Publicado: (2017)

Identification of a novel prognostic signature for HCC and analysis of costimulatory molecule-related lncRNA AC099850.3
por: Wang, Qi, et al.
Publicado: (2022)

Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis
por: Xue, Sheng, et al.
Publicado: (2022)

Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
por: Li, Xiaoying, et al.
Publicado: (2020)

Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
por: Liu, Shuzhen, et al.
Publicado: (2020)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ujnq4dpa5rbbmck0lqrf9f4j17